Skip to search.
 FTSE 100 Down 0.23%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
4.34 Up 0.06(1.29%) 16:00 - Nasdaq Real Time Price
Prev Close:4.28
Open:4.26
Bid:4.33 x 1100
Ask:4.34 x 1000
1y Target Est:15.25
Beta:2.71233
Earnings Date:26 Oct - 31 Oct (Est.)
Day's Range:4.26 - 4.36
52wk Range:4.08 - 9.91
Volume:80,176
Avg Vol (3m):878,264
Market Cap:306.13m
P/E (ttm):N/A
EPS (ttm):-0.94
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SGMO at this time.

Comparison

Symbol% ChgMkt Cap
SGMOUp 1.29%306.13m
LLYDown 0.52%82.51b
AMGNDown 0.42%127.81b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.11
Quarterly EPS Est (Sep-16) :-0.25
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback